Coombs Control

Anti-human globulin (Coombs) · class III · Until 04/12/2033

Registration no.
80134860301
Process no.
25351124263202359
Status
Until 04/12/2033
Device type
Anti-human globulin (Coombs) (GLOBULINA ANTI-HUMANA (COOMBS))
Risk class
III
Registration holder
GRIFOLS BRASIL LTDA CNPJ 02.513.899/0001-71 · 342 registrations
Manufacturer
MEDION GRIFOLS DIAGNOSTICS AG · Switzerland
Published
04/12/2023
Valid until
04/12/2033
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other anti-human globulin (coombs) registrations (29 in total, see all)

ProductClass HolderPublishedStatus
Coombs-Control IgG
80020690488
III BIO-RAD LABORATORIOS BRASIL LTDA 10/08/2026 Until 10/08/2036
Soro de Coombs
10159820274
III EBRAM PRODUTOS LABORATORIAIS LTDA 23/03/2026 Until 23/03/2036
ID-DAT IgG1/IgG3
80020690454
III BIO-RAD LABORATORIOS BRASIL LTDA 14/07/2025 Until 06/03/2037
ID-DC Screening II
80020690455
III BIO-RAD LABORATORIOS BRASIL LTDA 14/07/2025 Until 06/03/2037
ID-DC Screening I
80020690456
III BIO-RAD LABORATORIOS BRASIL LTDA 14/07/2025 Until 06/03/2037
Anti-Human-Globulin Color
80020690457
III BIO-RAD LABORATORIOS BRASIL LTDA 14/07/2025 Until 14/06/2031
Anti-IgG Uncolored
80020690459
III BIO-RAD LABORATORIOS BRASIL LTDA 14/07/2025 Until 16/08/2031
ID-LISS/Coombs
80020690460
III BIO-RAD LABORATORIOS BRASIL LTDA 14/07/2025 Until 06/02/2037